Congress – Page 24 – Policy & Medicine

Senate Hearing on Opioid Epidemic Focuses on Limiting Multiple Access Points

Robert Califf Confirmed as FDA Commissioner 89-4

Responsibility in Drug Advertising Act of 2016 – Introduced to Restrict DTC – Direct to Consumer Advertising

Congress Seeks Feedback on Site-Neutral Provision of Bipartisan Budget Act of 2015

Senate HELP Committee Moves Closer to Creating Corollary to 21st Century Cures

BioSimilars: FDA Panel Overwhelming Recommends Approval of Remicade BioSimilar, Congress Asks Tough Questions of FDA and CMS

An Update on the Nomination of FDA Commissioner Robert Califf

Testy Oversight and Government Reform Committee Hearing on Prescription Drug Pricing

Senators Wyden and Grassley Request Public Comments on Gilead Pricing

Improving Regulatory Transparency for New Medical Therapies Act